The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Incidence and Clinical Complications of Myelodysplastic Syndromes Among United States Medicare Beneficiaries
Open accessAbstract
Purpose: To determine the incidence and complications of myelodysplastic syndromes (MDS) among Medicare beneficiaries. Methods: Retrospective review of 2003 Medicare Standard Analytic Files utilizing International Classification of Diseases for Oncology ninth edition CM code 238.7 to identify new MDS patients, with 3-year follow-up. Results: Among 1,394,343 individuals in Medicare Standard Analytic Files age ≥ 65 years, 162 per 100,000 were coded as newly diagnosed MDS during 2003 yielding a calculated 45,000 new cases in the United States Medicare ≥ 65 years population. Patients with MDS were older (median age, 77 years), and over-represented by males. Among patients with MDS diagnosed during first quarter of 2003, 73.2% suffered cardiac-related events during 3-year follow-up, which exceeded the Medicare population (54.5%; P < .01) even when age adjusted (odds ratio, 2.10; P < .01). Significant increases in prevalence of diabetes (40.0% v 33.1%), dyspnea (49.4% v 28.5%), hepatic diseases (0.8% v 0.2%), and infections (sepsis: 22.5% v 6.1%) were noted in MDS (all P < .01) compared with the Medicare population. Patients with MDS requiring RBC transfusions had greater prevalence of these comorbidities. Acute myeloid leukemia developed within 3 years in 9.6%, with increased transformation among transfused (24.6%; P < .001). The 3-year Kaplan-Meier age-adjusted survival for MDS was 60.0%, which was significantly lower than the Medicare population (84.7%; hazard ratio, 3.08; P < .001), and mortality was further increased among transfused MDS (P < .01). In 2003, median payment for MDS was $16,181, compared to $1,575 for the Medicare population (P < .001). Conclusion: MDS is a common hematologic malignancy of the elderly, which places patients at risk for comorbid conditions. Transfusion dependency identifies patients with MDS at additional increased risk of organ impairment and shortened survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.12.3835 · Cited by 3,267
Guralnik, J. M., Eisenstaedt, R. S., Ferrucci, L., Klein, H. G., & Woodman, R. C. (2004) · Blood · doi:10.1182/blood-2004-05-1812 · Cited by 1,450
Malcovati, L., Germing, U., Kuendgen, A., Della Porta, M. G., Pascutto, C., Invernizzi, R., Giagounidis, A., Hildebrandt, B., Bernasconi, P., Knipp, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5696 · Cited by 1,032
Malcovati, L., Porta, M. G. D., Pascutto, C., Invernizzi, R., Boni, M., Travaglino, E., Passamonti, F., Arcaini, L., Maffioli, M., Bernasconi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.7038 · Cited by 865
The accuracy of Medicare's hospital claims data: progress has been made, but problems remain.
Fisher, E. S., Whaley, F. S., Krushat, W. M., Malenka, D. J., Fleming, C., Baron, J. A., & Hsia, D. C. (1992) · American Journal of Public Health · doi:10.2105/ajph.82.2.243 · Cited by 709
Rollison, D. E., Howlader, N., Smith, M. T., Strom, S. S., Merritt, W. D., Ries, L. A., Edwards, B. K., & List, A. F. (2008) · Blood · doi:10.1182/blood-2008-01-134858 · Cited by 663
Jollis, J. G., Ancukiewicz, M., DeLong, E. R., Pryor, D. B., Muhlbaier, L. H., & Mark, D. B. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-8-199310150-00011 · Cited by 625
Myelodysplastic syndromes: Incidence and survival in the United States
Ma, X., Does, M., Raza, A., & Mayne, S. T. (2007) · Cancer · doi:10.1002/cncr.22570 · Cited by 537
Myelodysplastic Syndromes — Coping with Ineffective Hematopoiesis
Cazzola, M., & Malcovati, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmp048266 · Cited by 343
Nimer, S. D. (2008) · Blood · doi:10.1182/blood-2007-08-078139 · Cited by 336
Sekeres, M. A., Schoonen, W. M., Kantarjian, H., List, A., Fryzek, J., Paquette, R., & Maciejewski, J. P. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn349 · Cited by 248
Sanz, G. F., Nomdedeu, B., Such, E., Bernal, T., Belkaid, M., Ardanaz, M. T., Marco, V., Pedro, C., Ramos, F., del Cañizo, M. C., et al. (2008) · Blood · doi:10.1182/blood.v112.11.640.640 · Cited by 119
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years
Kantarjian, H. M., O'Brien, S. M., Cortes, J. E., Wierda, W. G., Faderl, S. H., Garcia‐Manero, G., Issa, J. J., Estey, E. H., Keating, M. J., & Freireich, E. J. (2008) · Cancer · doi:10.1002/cncr.23655 · Cited by 99
Improved Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy
Leitch, H. A., Leger, C. S., Goodman, T. A., Wong, K. K., Wong, D. H. C., Ramadan, K. M., Rollins, M. D., Barnett, M. J., Galbraith, P. F., & Vickars, L. M. (2008) · Clinical Leukemia · doi:10.3816/clk.2008.n.026 · Cited by 75
Rosé, C., Bréchignac, S., Vassilief, D., Beyne‐Rauzy, O., Stamatoullas, A., Larbaa, D., Guerci‐Bresler, A., Roy, L., Dumazert, L., Mahé, B., et al. (2007) · Blood · doi:10.1182/blood.v110.11.249.249 · Cited by 73
Delea, T. E., Hagiwara, M., & Phatak, P. D. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802565867 · Cited by 61
The Epidemiology of Myelodysplastic Syndromes
Germing, U., Neukirchen, J., & Haas, R. R. (2008) · Clinical Leukemia · doi:10.3816/clk.2008.n.004 · Cited by 12
Stone, R. M., Sekeres, M. A., Garcia‐Manero, G., & Lyons, R. M. (2008) · PubMed · Cited by 8
Cited by
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Shallis, R. M., Wang, R., Davidoff, A., Ma, X., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.005 · Cited by 941
Malcovati, L., Hellström-Lindberg, E., Bowen, D., Adès, L., Cermak, J., del Cañizo, C., Della Porta, M. G., Fenaux, P., Gattermann, N., Germing, U., et al. (2013) · Blood · doi:10.1182/blood-2013-03-492884 · Cited by 669
Clinical significance of somatic mutation in unexplained blood cytopenia
Malcovati, L., Gallì, A., Travaglino, E., Ambaglio, I., Rizzo, E., Molteni, E., Elena, C., Ferretti, V. V., Catricalà, S., Bono, E., et al. (2017) · Blood · doi:10.1182/blood-2017-01-763425 · Cited by 478
Malcovati, L., Della Porta, M. G., Strupp, C., Ambaglio, I., Kuendgen, A., Nachtkamp, K., Travaglino, E., Invernizzi, R., Pascutto, C., Lazzarino, M., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.044602 · Cited by 282
The Pathophysiology of Transfusional Iron Overload
Porter, J. B., & Garbowski, M. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.04.003 · Cited by 120
Metadata
- Authors
- Goldberg, S. L., Chen, E., Corral, M., Guo, A., Mody-Patel, N., Pecora, A. L., & Laouri, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-06-10
- Volume
- 28
- Issue
- 17
- Pages
- 2847-2852
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2103020543
- Cited by
- 289
- References
- 19
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.